Immune Thrombocytopenic Purpura in Patients with COVID-19
  • Sabine Revuz
    Hôpitaux Privés de Metz, Metz, France
  • Nathalie Vernier
    Hôpitaux Privés de Metz, Metz, France
  • Leilah Saadi
    Hôpitaux Privés de Metz, Metz, France
  • Julien Campagne
    Hôpitaux Privés de Metz, Metz, France
  • Sophie Poussing
    Hôpitaux Privés de Metz, Metz, France
  • François Maurier
    Hôpitaux Privés de Metz, Metz, France

Keywords

COVID-19, SARS-CoV-2, thrombocytopenia, intravenous immunoglobulins

Abstract

We described three COVID-19-infected patients with profound immune thrombocytopenia causing haemorrhagic mucocutaneous complications. We conclude that an immune mechanism was responsible as common causes were excluded. Since corticoids were considered harmful in the circumstances, the patients were successfully treated with intravenous immunoglobulins without later relapse.

VIEW THE ENTIRE ARTICLE

References

  • Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020;368:m1091.

  • Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta 2020;506:145–148.

  • Zulfiqar AA, Lorenzo-Villalba N, Hassler P, Andrès E. Immune thrombocytopenic purpura in a patient with Covid-19. N Engl J Med 2020;382(18):e43.

  • Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 2019;3:3780–3817.

  • Henry BM, Vikse J, Benoit S, Favaloro EJ, Lippi G. Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin Chim Acta 2020;507:167–173.

    • Views: 1243
    HTML downloads: 317
    PDF downloads: 503

    Published: 2020-06-09
    Issue: 2020: Vol 7 No 7 (view)

    How to cite:
    1.
    Revuz S, Vernier N, Saadi L, Campagne J, Poussing S, Maurier F. Immune Thrombocytopenic Purpura in Patients with COVID-19. EJCRIM 2020;7 doi:10.12890/2020_001751.